eXoZymes, Inc. (EXOZ)
NASDAQ: EXOZ · Real-Time Price · USD
12.20
-0.31 (-2.48%)
May 9, 2025, 4:00 PM - Market closed

Company Description

eXoZymes, Inc. a development stage company focused on building a technology platform that can develop assets that can be reapplied multiple times in different markets with only small changes, while maintaining and capturing new fundamental IP in the application.

The company produces chemicals, including pharmaceuticals, fuels, materials, food additives, colors, fragrance and novel compounds.

Its platform also comprises one or more module which consist of one or more enzymes that work together to perform a defined biocatalytic conversion.

The company was formerly known as Invizyne Technologies, Inc. and changed its name to eXoZymes, Inc. in February 2025.

The company was founded in 2014 and is headquartered in Monrovia, California.

eXoZymes, Inc.
eXoZymes logo
Country United States
Founded 2014
Industry Biotechnology
Sector Healthcare
Employees 31
CEO Michael Heltzen

Contact Details

Address:
750 Royal Oaks Drive, Suite 106
Monrovia, California 91016
United States
Phone 626 415 1488
Website exozymes.com

Stock Details

Ticker Symbol EXOZ
Exchange NASDAQ
Stock Type Common Stock
Fiscal Year January - December
Reporting Currency USD
CIK Code 0002010788
ISIN Number US4618741098

Key Executives

Name Position
Michael Heltzen President and Chief Executive Officer
Dr. Tyler Korman Ph.D. Co-Founder and Vice President of Research
Dr. Paul Opgenorth Ph.D. Co-Founder and Vice President of Development
Fouad Nawaz Vice President of Finance
James U. Bowie Ph.D. Founder and Independent Director
Lasse H. Gorlitz Vice President of Communications
Michael Burns Executive Vice President of Energy Transition
Dr. Zachary Karl Ph.D. Vice President and Head of Business Development
Damien A. Perriman Chief Commercial Officer